DB818 is a potent inhibitor of Homeobox A9 (HOXA9). HOXA9 is a transcription factor regulating haematopoiesis and leukaemia cell proliferation, involving in acute myeloid leukaemia (AML). DB818 inhibits AML cell lines growth, induces apoptosis[1].
Molecular Weight:
360.44
Purity:
98.36
CAS Number:
[790241-43-9]
Formula:
C19H16N6S
Target:
Apoptosis
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted